Topoisomerase I/II-IN-10
Topoisomerase I/II-IN-10 is a Topoisomerase I/II inhibitor. Topoisomerase I/II-IN-10 inhibits TrxR1 activity, impairs the thioredoxin antioxidant system, and promotes oxidative stress. Topoisomerase I/II-IN-10 does not intercalate into DNA and does not induce DNA relaxation in the absence of topoisomerase. Topoisomerase I/II-IN-10 induces Apoptosis, increases the intracellular total oxidation state, and increases the Bax/Bcl-2 ratio. Topoisomerase I/II-IN-10 can be used for research on lung cancer.
For research use only. We do not sell to patients.
- Formula: C22H15F3N4O2
- Molecular Weight:424.38
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Topoisomerase Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
Topoisomerase I |
Topoisomerase II |
TrxR1 |
Bax |
Bcl-2 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
9.85 μM
|
Cytotoxicity against human A549 lung adenocarcinoma cells assessed as viability reduction after 24 hrs by MTT assay.
Cytotoxicity against human A549 lung adenocarcinoma cells assessed as viability reduction after 24 hrs by MTT assay.
|
42641467 |
| BEAS-2B | IC50 |
79.3 μM
|
Cytotoxicity against human BEAS-2B bronchial epithelial cells assessed as viability reduction after 24 hrs by MTT assay.
Cytotoxicity against human BEAS-2B bronchial epithelial cells assessed as viability reduction after 24 hrs by MTT assay.
|
42641467 |
In Vitro
Topoisomerase I/II-IN-10 (Compound 5i) (1 mM) does not intercalate into DNA and does not alter the migration of supercoiled DNA in a cell-free DNA intercalation assay[1].
Topoisomerase I/II-IN-10 (1 mM; incubated at 37°C for 30 min) completely inhibits topoisomerase I in the supercoiled DNA relaxation assay[1].
Topoisomerase I/II-IN-10 (1 mM) strongly inhibits the strand-passing activity of topoisomerase II, acting as a dual Topo I/II inhibitor[1].
Topoisomerase I/II-IN-10 (10 μM; 24 h) reduces TrxR1 activity in A549 cells[1].
Topoisomerase I/II-IN-10 (0.1-1000 μM; 24 h) exhibits antiproliferative activity against A549 lung adenocarcinoma cells with an IC50 of 9.85 μM and a BEAS-2B/A549 selectivity index of 8.05[1].
Topoisomerase I/II-IN-10 (10 μM; 24 h) increases Bax, decreases Bcl-2, and elevates the Bax/Bcl-2 ratio in A549 cells[1].
Topoisomerase I/II-IN-10 (10 μM; 24 h) induces apoptosis-related non-viable cells in A549 cells, with a ≥4-fold increase compared with the control[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:A549 human lung adenocarcinoma cells and BEAS-2B normal human bronchial epithelial cells
-
Concentration:0.1, 1, 10, 100, 1000 μM
-
Incubation Time:24 h (exposure); 4 h (MTT incubation)
-
Result:Had an IC50 of 9.85 μM in A549 cells and 79.3 μM in BEAS-2B cells, with a selectivity index (BEAS-2B/A549) of 8.05.
At 10 μM, it reduced A549 cell viability and altered cell morphology compared with control cells.
-
Cell Line:A549 cells
-
Concentration:10 μM
-
Incubation Time:24 h
-
Result:Elevated Bax protein levels, reduced Bcl-2 protein levels, and increased the Bax/Bcl-2 ratio in A549 cells compared with the control group.
-
Cell Line:A549 cells
-
Concentration:10 μM
-
Incubation Time:24 h; 30 min (Annexin V/PI incubation at room temperature in the dark)
-
Result:Caused a ≥4-fold increase in the proportion of nonviable cells compared with the control group.
Chemical Information
-
Molecular Weight 424.38
-
Formula C22H15F3N4O2
-
SMILES
O=C(C1=CC=CC=C1)NC2=NN=C(O2)C3=CC=CC=C3NC4=CC=CC(C(F)(F)F)=C4
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)